[New drugs. 8].
D001215:Asparaginase / Q000627:therapeutic use*; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use*; D003990:Dibenzoxepins / Q000009:adverse effects / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*
D003990:Dibenzoxepins; D003561:Cytarabine; D004295:Dihydroxyphenylalanine; D001215:Asparaginase
Neue Arzneistoffe. 8.